Engineered intein for improved production of protein-intein fusions
The invention discloses engineered non-self-cleaving inteins derived from Mxe GyrA inteins and methods of using such inteins to chemically modify proteins.
1. A non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 4 or having amino acid substitutions at amino acid positions Phe51, Ile105, Arg107, Phe110, Phe117, Phe124, Ser168 and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2.
2. A nucleic acid molecule encoding a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 4 or having amino acid substitutions at amino acid positions Phe51, Ile105, Arg107, Phe110, Phe117, Phe124, Ser168 and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2.
3. The nucleic acid molecule of claim 2 , wherein said nucleic acid molecule has the nucleotide, sequence set forth in SEQ ID NO: 3.
4. An expression vector comprising the nucleic acid molecule of claim 2 .
5. The expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 4 or having amino acid substitutions at amino acid positions Phe51, Ile105, Arg107, Phe110, Phe117, Phe124, Ser168 and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest.
6. A host cell transformed with the expression vector of claim 4 .
7. The host cell of claim 6 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
8. The host cell of claim 7 , wherein said host cell is a yeast cell.
9. A host cell transformed with the expression vector of claim 5 .
10. The host cell of claim 9 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
11. The host cell of claim 10 , wherein said host cell is a yeast cell.
12. A method for chemically functionalizing a protein of interest in a host cell, the method comprising the steps of:
(a) culturing a host cell, said host cell being transformed with an expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 4 or having amino acid substitutions at amino acid positions Phe51, Ile105, Arg107, Phe110, Phe117, Phe124, Ser168 and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest;
(b) expressing the fusion protein in said host cell; and
(c) exposing said fusion protein to a compound having a nucleophile and a functional group, wherein the nucleophile of the compound reacts with the fusion protein to release the protein of interest from the fusion protein, wherein the protein of interest is chemically linked to the functional group.
13. The method of claim 12 , wherein the host is selected from the group consisting of bacterial cells, yeast cells, mammalian cells, and fungal cells.
14. The method of claim 13 , wherein said host cell is a yeast cell.
15. The method of claim 12 , wherein the compound is 2-mercapthoethanesulfonic acid (MESNA).
16. The method of claim 12 , wherein the protein is chemically functionalized via expressed protein ligation (EPL).
17. The method of claim 12 , where the fusion protein expressed in step (b) is further purified.
18. A non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 6 or having amino acid substitutions at amino acid positions Val112, Cys114, Ala118, His144, Ser168, and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2.
19. A nucleic acid molecule encoding a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 6 or having amino acid substitutions at amino acid positions Val112, Cys114, Ala118, His144, Ser168 and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2.
20. The nucleic acid molecule of claim 19 , wherein said nucleic acid molecule has the nucleotide sequence set forth in SEQ ID NO: 5.
21. An expression vector comprising the nucleic acid molecule of claim 19 .
22. The expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 6 or having amino acid substitutions at amino acid positions Val112, Cys114, Ala118, His144, Ser168, and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest.
23. A host cell transformed with the expression vector of claim 21 .
24. The host cell of claim 23 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
25. The host cell of claim 24 , wherein said host cell is a yeast cell.
26. A host cell transformed with the expression vector of claim 22 .
27. The host cell of claim 26 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
28. The host cell of claim 27 , wherein said host cell is a yeast cell.
29. A method for chemically functionalizing a protein of interest in a host cell, the method comprising the steps of:
(a) culturing a host cell, said host cell being transformed with an expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 6 or having amino acid substitutions at amino acid positions Val112, Cys114, Ala118, His144, Ser168, and Ile190 in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest;
(b) expressing the fusion protein in said host cell; and
(c) exposing said fusion protein to a compound having a nucleophile and a functional group, wherein the nucleophile of the compound reacts with the fusion protein to release the protein of interest from the fusion protein, wherein the protein of interest is chemically linked to the functional group.
30. The method of claim 29 , wherein the host is selected from the group consisting of bacterial cells, yeast cells, mammalian cells, and fungal cells.
31. The method of claim 30 , wherein said host cell is a yeast cell.
32. The method of claim 29 , wherein the compound is 2-mercapthoethanesulfonic acid (MESNA).
33. The method of claim 29 , wherein the protein is chemically functionalized via expressed protein ligation (EPL).
34. The method of claim 29 , where the fusion protein expressed in step (b) is further purified.
35. A non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 8 or having amino acid substitutions at amino acid positions Arg107, Phe110, Cyst114, Ala118, Tyr129, His144, Asp158, and Arg160 in the amino acid sequence set forth in SEQ ID NO: 2.
36. A nucleic acid molecule encoding a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 8 or having amino acid substitutions at amino acid positions Arg107, Phe110, Cys114, Ala118, Tyr129, His144, Asp158, and Arg160 in the amino add sequence set forth in SEQ ID NO: 2.
37. The nucleic acid molecule of claim 36 , wherein said nucleic acid molecule has the nucleotide sequence set forth in SEQ ID NO: 7.
38. An expression vector comprising the nucleic acid molecule of claim 36 .
39. An expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 8 or having amino acid substitutions at amino acid positions Arg107, Phe110, Cys114, Ala118,Tyr129, His144, Asp158, and Arg160 in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest.
40. A host cell transformed with the expression vector of claim 38 .
41. The host cell of claim 40 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
42. The host cell of claim 41 , wherein said host cell is a yeast cell.
43. A host cell transformed with the expression vector of claim 39 .
44. The host cell of claim 43 , wherein said host cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, and a fungal cell.
45. The host cell of claim 44 , wherein said host cell is a yeast cell.
46. A method for chemically functionalizing a protein of interest in a host cell, the method comprising the steps of:
(a) culturing a host cell, said host cell being transformed with an expression vector encoding a fusion protein, wherein said fusion protein comprises a non-self-cleaving Mxe GyrA intein having the amino acid sequence set forth in SEQ ID NO: 8 or having amino acid substitutions at amino acid positions Arg107, Phe110, Cys114, Ala118, Tyr129, His144, Asp158, and Arg160 in the amino acid sequence set forth in SEQ ID NO: 2, in the amino acid sequence set forth in SEQ ID NO: 2 and a protein of interest;
(b) expressing the fusion protein in said host cell; and
(c) exposing said fusion protein to a compound having a nucleophile and a functional group, wherein the nucleophile of the compound reacts with the fusion protein to release the protein of interest from the fusion protein, wherein the protein of interest is chemically linked to the functional group.
47. The method of claim 46 , wherein the host is selected from the group consisting of bacterial cells, yeast cells, mammalian cells, and fungal cells.
48. The method of claim 47 , wherein said host cell is a yeast cell.
49. The method of claim 46 , wherein the compound is 2-mercapthoethanesulfonic acid (MESNA).
50. The method of claim 46 , wherein the protein is chemically functionalized via expressed protein ligation (EPL).
51. The method of claim 46 . where the fusion protein expressed in step (b) is further purified.